Shares of Quest Diagnostics Inc. (NYSE: DGX) plunged $7.54 to close at $94.57 after the Centers for Medicare and Medicaid Services proposed cuts to the reimbursement rates for lab tests.
Quest Diagnostics plunges on proposed reimbursement cuts
September 25, 2017 at 17:46 PM EDT
